SMRP-the Swedish study of Metabolic Risk in Psychosis
The purpose of our research is to investigate why people with psychosis often develop metabolic problems such as obesity, type 2 diabetes which are risk factors for cardiovascular disease.
Data and blood samples from people who visit psychosis clinics, mainly in Stockholm, enable us to study genetic, epigenetic and biochemical markers in relation to diagnosis, symptoms and pharmacological treatment.
Team-leaders: Catharina Lavebratt, Martin Schalling
Catharina Lavebratt
Principal ResearcherMartin Schalling
ProfessorCo-workers in the Translational Psychiatry Group:
Publications
Kumar P, Efstathopoulos P, Millischer V, Olsson E, Wei YB, Brüstle O, Schalling M, Villaescusa JC, Ösby U, Lavebratt C
Sci Rep 2018 08;8(1):12743
Kumar P, Millischer V, Villaescusa JC, Nilsson IAK, Östenson CG, Schalling M, Ösby U, Lavebratt C
Sci Rep 2017 08;7(1):7906
Hukic DS, Ösby U, Olsson E, Hilding A, Östenson CG, Gu HF, Ehrenborg E, Edman G, Schalling M, Lavebratt C, Frisén L
Psychiatr Genet 2017 12;27(6):210-218
Hukic DS, Lavebratt C, Olsson E, Östenson CG, Eriksson SV, Erlinge D, Schalling M, Ösby U
Psychiatry Res 2017 Apr;250():217-220